Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Non Operating Income (2017 - 2025)

Historic Non Operating Income for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to $433000.0.

  • Organogenesis Holdings' Non Operating Income rose 20334.13% to $433000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 20417.27%. This contributed to the annual value of -$1.5 million for FY2024, which is 2855.13% up from last year.
  • As of Q3 2025, Organogenesis Holdings' Non Operating Income stood at $433000.0, which was up 20334.13% from $742000.0 recorded in Q2 2025.
  • Organogenesis Holdings' Non Operating Income's 5-year high stood at $963000.0 during Q1 2025, with a 5-year trough of -$3.4 million in Q3 2021.
  • Its 5-year average for Non Operating Income is -$666947.4, with a median of -$566000.0 in 2023.
  • Its Non Operating Income has fluctuated over the past 5 years, first crashed by 156388.89% in 2023, then skyrocketed by 29613.03% in 2025.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Non Operating Income stood at -$862000.0 in 2021, then soared by 104.18% to $36000.0 in 2022, then plummeted by 1563.89% to -$527000.0 in 2023, then skyrocketed by 106.45% to $34000.0 in 2024, then surged by 1173.53% to $433000.0 in 2025.
  • Its Non Operating Income was $433000.0 in Q3 2025, compared to $742000.0 in Q2 2025 and $963000.0 in Q1 2025.